Alnylam Pharmaceuticals
ALNY
#632
Rank
$31.29 B
Marketcap
$241.75
Share price
-0.28%
Change (1 day)
64.85%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cost to borrow shares

Latest borrow fee for Alnylam Pharmaceuticals (ALNY) shares on Interactive Brokers: 0.2689% (annualized)

Shares available to borrow: 1900000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Alnylam Pharmaceuticals (ALNY) - cost to borrow in the last 7 days chart

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow in the last 7 days

Alnylam Pharmaceuticals (ALNY) - cost to borrow from 2025 to 2023

Alnylam Pharmaceuticals (ALNY) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.2753%2 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%1.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%1 M๐Ÿ‡บ๐Ÿ‡ธ USA
1.255%4.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
4.0556%0.35 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.25%0.7 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
0.2541%1.7 M๐Ÿ‡ซ๐Ÿ‡ท France
0.4081%10 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel